Skip to main content
PCSK9 inhibitors for severe COVID? Pilot trial signals of benefit
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
PCSK9 inhibitors for severe COVID? Pilot trial signals of benefit
User login
Username
Password
Reset your password
Concept
Lead
score
COVID-19
1
1
Lipids Management
0
0.99
PCSK9
0
0.98
Intubation
0
0.11
Cytokines
0
0.07
Anti-inflammatory Agents
0
0.04
Biomarker
0
0.04
Body Mass Index
0
0.04
CRISPR
0
0.04
Grant
0
0.04
Hospital
0
0.04
Interference
0
0.04
Interleukin
0
0.04
Lipoproteins
0
0.04
Metabolism
0
0.04
Michigan
0
0.04
New York
0
0.04
Oxygen Therapy
0
0.04
Receptors
0
0.04
Statins
0
0.04
Biologic Therapy
0
0.03
Genomic Medicine
0
0.03
Specialty
Lead
score
Cardiology
1
1
Diabetes & Endocrinology
0
0.7
Pulmonary Medicine
0
0.9
Infectious Diseases
0
0.8
Edit Tags